Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
<p>Dr Kevin Maki, from Midwest Biomedical Research, speaks to us about his latest review about the effect of omega3 supplementation on cardiometabolic health.</p>
Dr. James Matera, nephrologist and co-director of physician integration, answers questions about cardiometabolic risk in the United States as well as management of patients with chronic kidney disease. ...
Dr William Boden from the VA New England Healthcare System discusses the key takeaways from his session about coronary stenting at the American Society for Preventive Cardiology's 2018 Congress on CVD...
Dr. James R. Gavin III, professor of medicine at the Morehouse School of Medicine in Atlanta, Georgia, answers questions about managing patients with cardiometabolic disease, especially those with diabetes...
Dr. Donna H. Ryan, the executive director at Pennington Biomedical Research Center in Baton Rouge, Louisiana, discusses managing and treating patients with cardiometabolic disease, and specifically those...
In this podcast, Dr. Paul S. Jellinger, the chair of the writing committee, explains the new AACE/ACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease.
